# R & B Medical Group Inc. – FDA Inspection, Sep 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/r-b-medical-group-inc/456a9d98-111a-4607-ae74-5f45133e76e2
Source feed: FDA_Inspections

> FDA inspection 1102975 of R & B Medical Group Inc., September 25, 2019. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 1271. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102975
- Company Name: R & B Medical Group Inc.
- Inspection Date: 2019-09-25
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 6
- Enforcement Type: WARNING_LETTER

## Related Documents

- FDA Inspection 1150365 - 2021-08-12
- FDA Inspection 977932 - 2016-06-14

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)
- [Issuing Officer](https://www.keypedia.com/people/laurissa-s-flowers/27453525-c2fc-4a05-9cdc-7a1ed884304f)

Company: https://www.keypedia.com/companies/r-b-medical-group-inc/cfc94659-cdd7-4462-af33-36be815fbee0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d